Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1

Biochemical Pharmacology

Volumn 74, Issue 2, 2007, Pages 317-326

  Wan, Hui Xin ^a   Zhou, Caihong ^b   Zhang, Yueyun ^b   Sun, Meiling ^b   Wang, Xin ^a   Yu, Hong ^b   Yang, Xiaoke ^b   Ye, Richard D ^c   Shen, Jing Kang ^a   Wang, Ming Wei ^b  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b National Center for Drug Screening   (China)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Chemotactic peptides; Formyl peptide receptor like 1; Peptidomimetic; Structure activity relationship; Trp Lys Tyr Met Val d Met

Indexed keywords

AMINO ACID; FORMYLPEPTIDE RECEPTOR LIKE 1; LYSINE; METHIONINE; PHENYLALANYLMETHIONYLLEUCYLPHENYLALANINE; SYNTHETIC PEPTIDE; TRYPTOPHYLASPARAGINYLLEUCYLGLUTAMYLTYROSYLMETHIONINE; TRYPTOPHYLLYSYLTYROSYLMETHIONYLVALYLMETHIONINE; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYDROGEN BOND; NEUTROPHIL; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

BETA-N-ACETYLHEXOSAMINIDASE; CHEMOTACTIC FACTORS; CHEMOTAXIS; HELA CELLS; HUMANS; OLIGOPEPTIDES; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34249993122     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.04.016     Document Type: Article

References (29)

1. Le Y.Y., Murphy P.M., and Wang J.M. Formyl-peptide receptors revisited. Trends Immunol 23 (2002) 541-548
2. Prossnitz E.R., and Ye R.D. The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol Ther 74 (1997) 73-102
3. Boulay F.M., Brouchon T.L., and Vignais P. The human N-formylpeptide receptor: characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry 29 (1990) 11123-11133
4. Bokoch G.M. Chemoattractant signaling and leukocyte activation. Blood 86 (1995) 1649-1660
5. Murphy P.M., Ozcelik T., Kenney R.T., Tiffany H.L., McDermott D., and Francke U. A structural homologue of the N-formyl peptide receptor: characterization and chromosome mapping of a peptide chemoattractant receptor family. J Biol Chem 267 (1992) 7637-7643
6. Ye R.D., Cavanagh S.L., Quehenberger O., Prossnitz E.R., and Cochrane C.G. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem Biophys Res Commun 184 (1992) 582-589
7. Fiore S., Maddox J.F., Perez H.D., and Serhan C.N. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J Exp Med 180 (1994) 253-260
8. Su S.B., Gong W.H., Gao J.L., Shen W.P., Grimm M.C., Deng X., et al. T20/DP178, an ectodomain peptide of human immunodeficiency virus type 1 gp41, is an activator of human phagocyte N-formyl peptide receptor. Blood 93 (1999) 3885-3892
9. Su S.B., Gong W.H., Gao J.L., Shen W., Murphy P.M., Oppenheim J.J., et al. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 189 (1999) 395-402
10. Harada M., HabataY, Hosoya M., Nishi K., Fujii R., Kobayashi M., et al. N-formylated humanin activates both formyl peptide receptor-like 1 and 2. Biochem Biophy Res Commun 324 (2004) 255-261
11. Le Y.Y., Gong W.H., Tiffany H.L., Tumanov A., Nedospasov S., Shen W., et al. Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J Neurosci 21 (2001) RC123
12. Cui Y., Le Y., Yazawa H., Gong W.H., and Wang J.M. Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J Leukoc Biol 72 (2002) 628-635
13. Le Y.Y., Yazawa H., Gong W.H., Yu Z., Ferrans V.J., Murphy P.M., et al. The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1. J Immunol 166 (2001) 1448-1451
14. Mills J.S. Peptides derived from HIV-1, HIV-2, Ebola virus, SARS coronavirus and coronavirus 229E exhibit high affinity binding to the formyl peptide receptor. Biochim Biophy Acta 1762 (2006) 693-703
15. Klein C., Paul J.I., Sauve K., Schmidt M.M., Arcangeli L., Ransom J., et al. Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast. Nat Biotechnol 16 (1998) 1334-1337
16. Baek S.H., Seo J.K., Chae C.B., Suh P.G., and Ryu S.H. Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries. J Biol Chem 271 (1996) 8170-8175
17. Bae Y.S., Ju S.A., Kim J.Y., Seo J.K., and Baek S.H. Trp-Lys-Tyr-Met-Val-d-Met stimulates superoxide generation and killing of Staphylococcus aureus via phospholipase D activation in human monocytes. J Leukoc Biol 65 (1999) 241-248
18. Le Y.Y., Gong W.H., Li B.Q., Dunlop N.M., Shen W., Su S.B., et al. Utilization of two seven-transmembrane, G-protein coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J Immunol 163 (1999) 6777-6784
19. 2 specifically activates neutrophils through FPRL1/Lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J Biol Chem 276 (2001) 21585-21593
20. Li B.Q., Wetzel M.A., Mikovits J.A., Henderson E.E., Rogers T.J., Gong W.H., et al. The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1. Blood 97 (2001) 2941-2947
21. Nanamori M., Cheng X.Y., Mei J.H., Sang H.R., Xuan Y.X., Zhou C.H., et al. A novel nonpeptide ligand for formyl peptide receptor-like 1. Mol Pharmacol 66 (2004) 1213-1222
22. Roland W.B., Xu H., Zou X.M., Muller K., Golden J., Frohn M., et al. Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents. Bioorg Med Chem Lett 16 (2006) 3713-3718
23. He R., Tan L., Browning D.D., Wang J.M., and Ye R.D. The synthetic peptide Trp-Lys-Tyr-Met-Val-d-Met is a potent chemotactic agonist for mouse formyl peptide receptor. J Immunol 165 (2000) 4598-4605
24. Yan P., Nanamori M., Sun M., Zhou C., Cheng N., Li N., et al. The immunosuppressant cyclosporin A antagonizes human formyl peptide receptor through inhibition of cognate ligand binding. J Immunol 177 (2006) 7050-7058
25. Atherton E., and Sheppard R.C. Solid phase peptide synthesis: a practical approach (1989), Oxford University Press, Oxford
26. Bae Y.S., Yi H.J., Lee H.Y., Jo E.J., Kim J.I., Lee T.G., et al. Differential activation of formyl peptide receptor-like 1 by peptide ligands. J Immunol 171 (2003) 6807-6813
27. Bae Y.S., Song J.Y., Kim Y.D., Her R., Ye R.D., Kwak J.Y., et al. Differential activation of formyl peptide receptor signaling by peptide ligands. Mol Pharmacol 64 (2003) 841-847
28. Kobilka B.K., Kobilka T.S., Daniel K., Regan J.W., Caron M.G., and Lefkowitz R.J. Chimeric alpha 2-, beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 240 (1988) 1310-1316
29. Le Y.Y., Ye R.D., Gong W.H., Li J.X., Iribarren P., and Wang J.M. Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis. FEBS 272 (2005) 769-778